Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma.
about
MiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human gliomaIdentification of a CpG island methylator phenotype that defines a distinct subgroup of gliomaDNA methylation represses IFN-gamma-induced and signal transducer and activator of transcription 1-mediated IFN regulatory factor 8 activation in colon carcinoma cellsMethylation-dependent silencing of CST6 in primary human breast tumors and metastatic lesionsEpigenetic principles and mechanisms underlying nervous system functions in health and diseaseProteomic analysis of gliomas.Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas.Cystatin E/M suppresses legumain activity and invasion of human melanomaCpG island hypermethylation in human astrocytomasDNA methylation in glioblastoma: impact on gene expression and clinical outcomeTSPYL2 is important for G1 checkpoint maintenance upon DNA damage.Differentially expressed nucleolar transforming growth factor-beta1 target (DENTT) exhibits an inhibitory role on tumorigenesisRe-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosisInactivation of the cystatin E/M tumor suppressor gene in cervical cancerMicroenvironmental control of malignancy exerted by RNASET2, a widely conserved extracellular RNase.Genome-wide methylation profiling identifies an essential role of reactive oxygen species in pediatric glioblastoma multiforme and validates a methylome specific for H3 histone family 3A with absence of G-CIMP/isocitrate dehydrogenase 1 mutation.DNA methylation-dependent silencing of CST6 in human breast cancer cell lines.DNA methylation-mediated silencing of nonsteroidal anti-inflammatory drug-activated gene (NAG-1/GDF15) in glioma cell linesOverexpression of MBD2 in glioblastoma maintains epigenetic silencing and inhibits the antiangiogenic function of the tumor suppressor gene BAI1Integrative epigenomic and genomic filtering for methylation markers in hepatocellular carcinomas.Deletion or epigenetic silencing of AJAP1 on 1p36 in glioblastoma.High-risk oral leukoplakia is associated with aberrant promoter methylation of multiple genesDNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain TumorsModulation by decitabine of gene expression and growth of osteosarcoma U2OS cells in vitro and in xenografts: identification of apoptotic genes as targets for demethylationDecitabine Treatment of Glioma-Initiating Cells Enhances Immune Recognition and KillingDifferential secretome analysis reveals CST6 as a suppressor of breast cancer bone metastasisTROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma.Testis specific Y-like 5: gene expression, methylation and implications for drug sensitivity in prostate carcinomaIdentification of genes underlying different methylation profiles in refractory anemia with excess blast and refractory cytopenia with multilineage dysplasia in myelodysplastic syndrome.Cathepsin B and uPAR regulate self-renewal of glioma-initiating cells through GLI-regulated Sox2 and Bmi1 expressionThe gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasisEpigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.Invasion suppressor cystatin E/M (CST6): high-level cell type-specific expression in normal brain and epigenetic silencing in gliomas.Identifying genes progressively silenced in preneoplastic and neoplastic liver tissues.Randomized Phase III controlled trials of therapy in malignant glioma: where are we after 40 years?Aberrant methylation and reduced expression of LHX9 in malignant gliomas of childhood.Epigenetic changes in gliomas.Frequent loss of cystatin E/M expression implicated in the progression of prostate cancer.Epigenetic markers in human gliomas: prospects for therapeutic intervention.Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors.
P2860
Q21245768-75DE628B-64AA-4ED7-8448-1EDD8EEFD8E6Q24612429-9A0CA8DC-A655-4372-B2F6-DFDEE8C528F7Q24644027-6DB565DE-84A5-4581-9796-E213135075C2Q24648542-8AD1525F-77E9-4757-83ED-1957840403CEQ24657549-3D749078-B259-4F0F-9DE9-CCA10D37053CQ33309684-572C3D3C-2910-47EE-ACDD-5EBA59BF53ADQ33381892-1E85A159-80A4-40A6-905D-915E21A6027CQ33523914-D25C2B17-ED92-40DC-8DC9-D6BEB93C2DDDQ33766932-F98ED85A-DC42-4D67-9A8A-6223FBC0CA84Q33771159-71EA3E77-A8EF-4963-91F9-B88B8AFBF039Q33955132-9EE67CD9-09EC-4AC7-9CB0-BBBABC323C17Q33986332-08F9500A-E8F7-473C-B034-7077720DB32AQ34134446-63591936-ECDC-4D67-B7CE-15B1F7A9A28AQ34282467-C0B140FA-4D7F-4BC6-B9E5-21502E70ADD6Q34508726-103F9A41-6256-401E-9003-9183D52BFF66Q34511715-0FDF7424-42DE-465A-BA65-A4978C8CECC1Q34574105-47F9A7CA-09E5-4881-9052-1EF016104F4FQ35098017-78BCEC79-8B0D-4F51-BB20-AFE0A5E50F88Q35190706-4E8958D0-F889-4ED9-884A-E52B40E238F8Q35658932-B23EF635-8F65-4CFD-9BC5-AF39758BA2CBQ35783190-E68E08EB-7B6D-4F86-B3A0-69F725FF9E19Q36038578-F93AE9FB-6905-4D48-9D61-69E59CABF4FBQ36069167-2A5B4030-AFB3-42C8-BE9C-6946E9514D49Q36082658-BA263C17-56BA-4CAD-AAE6-C107F795D45CQ36118290-A6F0B25B-129D-491D-9BEA-0D2F615CBB34Q36210416-FB1927AD-8A00-44C4-A25D-68CEBA9CB2ACQ36238661-C5484344-C46C-4B9F-A40B-6941F1099A67Q36290399-87A8B808-E7D8-4C7F-A576-E404E5495107Q36297655-536B7F52-D649-49B8-A8BA-48803D23BEEFQ36636347-7BF2B48E-52BC-45C1-8451-D66C204A58B5Q36691376-CA4E338D-53D9-4D51-A278-B635F7A9A104Q36801625-37C608CE-4F63-48B2-9537-2593E32900B9Q36953248-78D7481F-728E-479B-8FCB-90372B6F6461Q37087309-7BA90063-0B77-4B4A-96B9-8E68C7EC940FQ37196375-039E276E-86EC-4416-976B-7B6A38490DF0Q37229938-5AC09401-6F72-4B05-8AEC-609B0441EDB6Q37287032-5662A2F9-3452-4E83-B4D2-3073019D340CQ37294189-6FFFF04D-3B38-49BE-9093-D3CE331E7813Q37301207-8F455C9B-2B69-47BB-8F33-811A63D5BB3BQ37347838-3373A699-48D0-4F27-9661-736317D57C0E
P2860
Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Epigenomic profiling reveals n ...... silencing in malignant glioma.
@en
type
label
Epigenomic profiling reveals n ...... silencing in malignant glioma.
@en
prefLabel
Epigenomic profiling reveals n ...... silencing in malignant glioma.
@en
P2093
P1433
P1476
Epigenomic profiling reveals n ...... silencing in malignant glioma
@en
P2093
C Robert Fields
Jeong Hoon Kim
Sheng Zhong
Tae-You Kim
P304
P356
10.1158/0008-5472.CAN-05-4552
P407
P577
2006-08-01T00:00:00Z